Medicare

The AJMC® Medicare compendium is a comprehensive resource for clinical news and expert insights on issues that affect Medicare beneficiaries with a focus on polypharmacy, reimbursement challenges, and other topics related to seniors.

Latest News

glp-1 Wegovy, semaglutide | Image credit: Patrick Bay Damsted - stock.adobe.com
Can Medicare Sustain Widespread Access to GLP-1 Therapies?

April 25th 2025

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.

AJMC
Impact of Hospital-Physician Integration on Medicare Patient Mix

April 11th 2025

CMS. | Image Credit: Postmodern Studio - stock.adobe.com
Survey Finds Slow Start on CMS Interoperability Rule Implementation

April 10th 2025

AJMC
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

April 4th 2025

inflation reduction act | Image credit: Vitalii Vodolazskyi -stock.adobe.com
The IRA’s Unintended Consequences for Drug Pricing and Coverage

April 2nd 2025

Examining the Benefit of an Innovative Enhanced Medication Therapy Management Model

In this series of articles, the authors present the MedWise Risk Score, an enhanced medication therapy management model, and its impact on medication safety reviews and health care outcomes.

AJMC Supplement Cover for Examining the Benefit of an Innovative Enhanced Medication Therapy Management Model
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo